158 related articles for article (PubMed ID: 9486487)
1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
Goldman JM; Schmitz N; Niethammer D; Gratwohl A
Bone Marrow Transplant; 1998 Jan; 21(1):1-7. PubMed ID: 9486487
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Bone Marrow Transplant; 2002 Apr; 29(8):639-46. PubMed ID: 12180107
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D;
Bone Marrow Transplant; 2010 Feb; 45(2):219-34. PubMed ID: 19584824
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Gratwohl A; Goldman JM
Bone Marrow Transplant; 1996 Apr; 17(4):471-7. PubMed ID: 8722341
[TBL] [Abstract][Full Text] [Related]
6. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
7. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Bone Marrow Transplant; 1994 Jan; 13(1):5-10. PubMed ID: 8019452
[TBL] [Abstract][Full Text] [Related]
9. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; Baldomero H
Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
[TBL] [Abstract][Full Text] [Related]
10. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
Gratwohl A; Schmid O; Baldomero H; Horisberger B; Urbano-Ispizua A;
Bone Marrow Transplant; 2004 Nov; 34(10):855-75. PubMed ID: 15517006
[TBL] [Abstract][Full Text] [Related]
11. Incidence of bone marrow transplantation in Europe. Report from the European Group for Blood and Marrow Transplantation.
Gratwohl A
Arch Immunol Ther Exp (Warsz); 1995; 43(2):77-81. PubMed ID: 8744719
[TBL] [Abstract][Full Text] [Related]
12. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
[TBL] [Abstract][Full Text] [Related]
13. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
14. [The bone-marrow transplantation program in Hungary: report from the period 1990-1995].
Petrányi G; Masszi T; Tímár L; Kriván G; Pálóczi K; Nagy K; Fekete S; Reményi P; Torbágyi E; Dénes R; Kelemen E
Orv Hetil; 1996 Oct; 137(40):2203-8. PubMed ID: 8927370
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation activity in Europe 1999.
Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
[TBL] [Abstract][Full Text] [Related]
16. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
17. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
Miano M; Labopin M; Hartmann O; Angelucci E; Cornish J; Gluckman E; Locatelli F; Fischer A; Egeler RM; Or R; Peters C; Ortega J; Veys P; Bordigoni P; Iori AP; Niethammer D; Rocha V; Dini G;
Bone Marrow Transplant; 2007 Jan; 39(2):89-99. PubMed ID: 17213848
[TBL] [Abstract][Full Text] [Related]
19. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
20. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
